Global /Japan /Healthcare /Drug Manufacturers - General /4577

Daito Pharmaceutical Co.,Ltd.

4577

• TSE: 4577 • Delayed

1,261JPY 0.1%

7.88 USD

As of 5 June 2026, Daito Pharmaceutical Co.,Ltd. has a market cap of $227.06M USD, ranking #20296 globally and #1616 in Japan. It ranks #1823 in the Healthcare sector, and #664 in the Drug Manufacturers - General industry.

Global Rank

20296

Country Rank

1616

Sector Rank

1823

Industry Rank

664

Key Stats

Market Cap

$227.06MUSD

36.34B JPY

Enterprise Value

$279.26MUSD

44.69B JPY

Revenue (TTM)

$317.23MUSD

50.77B JPY

Net Income (TTM)

$18.48MUSD

2.96B JPY

Profit Margin

5.8%

PE Ratio

12.7

Forward PE

14.0

PS Ratio

0.7

PB Ratio

0.7

Company Profile

Country (HQ)

Japan

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Hiroshi Matsumori open_in_new

Employees

1,073

Founded

1942

Website

daitonet.co.jp open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0.1%	-4.2%	-14%	-5.8%	1.9%	-7.1%	23%	11%	-21%

News

Markets

Exchange	Ticker	Price	Quotes
Tokyo Stock Exchange (TSE / TYO) MIC: XTKS PRIMARY	4577 ダイト株式会社 ISIN: JP3486150000 Shares Out.: Shares Outstanding: 27.922M¹ Shares Float: 22.79M² TV: TradingView: TSE: 4577 SA: Stock Analysis: TYO: 4577 YF: Yahoo Finance: 4577.T GF: Google Finance: TYO: 4577 BA: Barron's: 4577 MS: Morningstar: XTKS: 4577	1,261 JPY	TV: TradingView: TSE: 4577 SA: Stock Analysis: TYO: 4577 YF: Yahoo Finance: 4577.T GF: Google Finance: TYO: 4577 BA: Barron's: 4577 MS: Morningstar: XTKS: 4577

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Daito Pharmaceutical Co.,Ltd.

Daito Pharmaceutical Co.,Ltd. engages in the manufacture and sale of pharmaceutical products in Japan and internationally. It offers active pharmaceutical ingredients for generic drugs; develops and manufactures generic and over-the-counter drugs; and contract manufacturing services for ethical drugs. The company is also involved in the wholesale of pharmaceutical and veterinary medicine. It exports its products to the United States, as well as European and Asian countries. The company was formerly known as Daito Corporation and changed its name to Daito Pharmaceutical Co.,Ltd. in 1992. Daito Pharmaceutical Co.,Ltd. was incorporated in 1942 and is headquartered in Toyama, Japan.

Similar Companies

Industry: Drug Manufacturers - General (Japan)

Name	Market Cap (USD) diff.	PE	Country
Chugai Pharmaceutical Co., Ltd. TSE: 4519	$81.66B 13.07T JPY 36K%	28.9	Japan
Takeda Pharmaceutical Company Ltd. TSE: 4502	$52.21B 8.36T JPY 23K%	75.1	Japan
Otsuka Holdings Co., Ltd. TSE: 4578	$36.84B 5.9T JPY 16K%	15.7	Japan
Daiichi Sankyo Company, Ltd. TSE: 4568	$30.37B 4.86T JPY 13K%	16.2	Japan
Astellas Pharma Inc. TSE: 4503	$25.82B 4.13T JPY 11K%	14.2	Japan
Shionogi & Co., Ltd. TSE: 4507	$16.91B 2.71T JPY 7K%	13.9	Japan

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 335K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 241K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 159K%	97.4	United States
Roche Holding AG SIX: RO	$324.68B 256.25B CHF 143K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$289.25B 215.59B GBP 127K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$277.35B 218.9B CHF 122K%	20.5	Switzerland

chevron_leftBack